GLP-1 blockers have other beneficial effects outside of the GI tract: Introduction GLP-1 (glucagon-like peptide-1) receptors (GLP-1R) are G-protein-coupled receptors widely expressed in the central nervous system (CNS)
THE MATH THAT MAKES YOU STOP AND THINK Neurodevelopmental disorder rate: 1 in 36 children 3.6 million births per year in the USA 1:36 = 100,000 children diagnosed annually 65% of pregnant women take acetaminophen (2.3 million women annually) At least 10% have compromised glutathione (PCOS, IVF, poor diet, chemical exposure, genetics) Thats 200,000+ pregnancies per year where acetaminophen depletes the molecule needed for healthy brain development If even half of those 200,000 vulnerable pregnancies result in developmental issues, youve accounted for a significant portion of the affected population
About two thirds of PCOS patients suffer from insulin resistance often leading to the development of the metabolic syndrome (130)
Is SkinnyRX FDA-Approved and Safe To Use
The clinical data on peptides for this demographic is encouraging
The muscle loss problem with GLP-1 therapy This is the conversation that does not get enough attention